Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Wlodzimierz Ruka"'
Autor:
Wlodzimierz Ruka, Zbigniew Nowecki, M. Symonides, Piotr Rutkowski, Konrad Ptaszyński, Maria Debiec-Rychter, Wanda Michej
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 25:264-270
Background Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma of the skin characterized by the presence of specific COL1A1–PDGFB fusion protein, which appears as a consequence of the t(17;22) (q22;q13) translocation. Objective The
Autor:
Marcin Zdzienicki, Urszula Grzesiakowska, Piotr Rutkowski, Wlodzimierz Ruka, Tadeusz Morysiński, Konrad Ptaszyński, Elżbieta Bylina, Donata Makuła, Zbigniew Nowecki
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 78:494-498
To assess the outcomes of radiotherapy, in terms of local control and treatment complications, of advanced or difficult giant cell tumors of bone (GCTB) that could not be treated by surgery.Among 122 consecutive patients with confirmed GCTB from 1985
Autor:
Piotr Rutkowski, M. Symonides, Marcin Zdzienicki, Zbigniew Nowecki, Wlodzimierz Ruka, Magdalena Rosinska, Elżbieta Bylina, Wanda Michej, Wirginiusz Dziewirski
Publikováno v:
International Journal of Dermatology. 49:907-913
Background The impact of age on melanoma patient outcomes is uncertain. Objective The aim of the study was to analyze the characteristics and treatment outcomes in cutaneous melanoma patients ≥ 65 years of age with lymph node metastases. Methods We
Autor:
Jadwiga Kulik, Michej Wanda, Alexander C.J. van Akkooi, Janusz A. Siedlecki, Piotr Rutkowski, Wlodzimierz Ruka, Alexander M.M. Eggermont, Zbigniew Nowecki
Publikováno v:
Annals of Surgical Oncology, 17(12), 3314-3323. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology
We assessed molecular (presence of melanoma cells markers in lymph fluid [LY]) and pathological features (sentinel lymph node [SN] tumor burden according to Rotterdam criteria, metastases microanatomic location) and correlated them with survival and
Autor:
Tadeusz Morysiński, Anna Kulik, Jarosław Łyczek, Wlodzimierz Ruka, Maciej Sałamacha, Piotr Rutkowski, Zbigniew Nowecki, Maria Kawczyńska, Anetta Kasprowicz, Wirginiusz Dziewirski
Publikováno v:
Journal of Contemporary Brachytherapy. 1:14-23
Purpose: The primary aim of this work was to analyze feasibility of combined treatment of retroperitoneal sarco- mas (RS): surgery (S) and intraoperative brachytherapy (IOBRT). The secondary aim was to analyze results and com- plications after this t
Autor:
Wlodzimierz Ruka, Janusz A. Siedlecki, Zbigniew Nowecki, A. Szawłowski, Wirginiusz Dziewirski, Urszula Grzesiakowska, Piotr Rutkowski, Maria Debiec-Rychter, Wanda Michej
Publikováno v:
European Journal of Surgical Oncology (EJSO). 35:87-91
Aim Sunitinib malate therapy in inoperable and/or metastatic gastrointestinal stromal tumor (GIST) resistant to imatinib mesylate may facilitate surgical removal of residual disease. We explored this possibility in the course of treating patients as
Publikováno v:
Melanoma Research. 18:246-252
Reverse transcriptase-polymerase chain reaction (RT-PCR)-mediated detection of melanoma cells may be a prognostic factor for disease outcome. We investigated the presence of melanoma cells in lymphatic drainage and blood in melanoma patients after ly
Publikováno v:
Molecular Diagnosis & Therapy. 12:131-143
The common feature of gastrointestinal stromal tumors (GISTs) is the expression of KIT protein or acquisition of activating, constitutive mutations in the KIT or platelet-derived growth factor receptor alpha (PDGFRA) genes that are the early oncogeni
Publikováno v:
Annals of Surgical Oncology. 13:1655-1663
We analyzed the outcomes and factors associated with false-negative (FN) results of sentinel lymph node (SLN) biopsy findings in patients with cutaneous melanoma. SLN biopsy failure rate was defined as nodal recurrence in the biopsied regional basin
Autor:
Piotr Rutkowski, Wlodzimierz Ruka, Z. Zurawski, Wirginiusz Dziewirski, Anna Nasierowska-Guttmejer, Zbigniew Nowecki, Tomasz Świtaj
Publikováno v:
European Journal of Cancer. 42:159-164
This study has analyzed the incidence of in transit/local recurrences (IT/LR) in melanoma patients after sentinel node (SLN) biopsy; completion lymph node dissection (CLND) that was performed due to positive node; and therapeutic LND (TLND) due to cl